1971
Treatment of Advanced Hodgkin's Disease with [1,3 Bis (2-Chloroethyl)-L-Nitrosourea] BCNU
Young R, DeVita V, Serpick A, Canellos G. Treatment of Advanced Hodgkin's Disease with [1,3 Bis (2-Chloroethyl)-L-Nitrosourea] BCNU. New England Journal Of Medicine 1971, 285: 475-479. PMID: 5558887, DOI: 10.1056/nejm197108262850902.Peer-Reviewed Original Research
1967
The physiological disposition of the carcinostatic 1,3‐bis(2‐chloroethyU‐l‐nitrosourea (BCNU) in man and animals
DeVita V, Denham C, Davidson J, Oliverio V. The physiological disposition of the carcinostatic 1,3‐bis(2‐chloroethyU‐l‐nitrosourea (BCNU) in man and animals. Clinical Pharmacology & Therapeutics 1967, 8: 566-577. PMID: 4951973, DOI: 10.1002/cpt196784566.Peer-Reviewed Original Research
1966
Pigmentation Due to a New Antitumor Agent: Effects of Topical Application of BCNU [1,3-Bis(2-Chloroethyl)-1-Nitrosourea]
FROST P, DeVITA V. Pigmentation Due to a New Antitumor Agent: Effects of Topical Application of BCNU [1,3-Bis(2-Chloroethyl)-1-Nitrosourea]. JAMA Dermatology 1966, 94: 265-268. DOI: 10.1001/archderm.1966.01600270015003.Peer-Reviewed Original Research